GGrantIndex
Sort

50,496 grants matching lung cancer

(2/2) TUFCCC/HC Regional Comprehensive Cancer Health Disparity Partnership

$1,008,742
Olorunseun O Ogunwobi · Hunter College · U54 · FY2021 · CA

Preclinical Mouse Models for Studying Immune Checkpoint Inhibitor Response

$1,008,673
Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

PROSTATE, LUNG, COLORECTAL, AND OVARIAN (PLCO) CANCER SCREENING TRIAL - LABORA

$1,008,581
David S Chia · · N01 · FY2007 · CA

Mechanism of action and therapeutic utility of stimulatory CpG oligonucleotides

$1,008,580
Dennis Klinman · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

Bio-Therapies for the Treatment of Cancer

$1,008,466
David Fitzgerald · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

Molecular, Cellular, and Tissue Characterization Unit

$1,008,368
Dana Pe'er · Sloan-Kettering Inst Can Research · U2C · FY2021 · CA

(2/2) TUFCCC/HC Regional Comprehensive Cancer Health Disparity Partnership

$1,008,081
Olorunseun O Ogunwobi · Hunter College · U54 · FY2019 · CA

Cancer Care Outcomes Research &Surveillance Consortium

$1,007,991
Harvard University (Medical School) · U01 · FY2005 · CA

CCCWFU Research Base Grant

$1,007,792
Wake Forest University Health Sciences · U10 · FY2002 · CA

Late Effects of Treatment in Wilms Tumor Survivors and Offspring

$1,007,340
Norman E Breslow · Fred Hutchinson Cancer Research Center · R01 · FY2011 · CA

Inhaled Fasudil and DETA NONOate CAR-Targeted Liposomes for PAH

$1,006,870
Fakhrul Ahsan · Vascular Biosciences · R42 · FY2022 · HL

Synthetic Approaches to Carcinogen-Linked Oligonucleotides

$1,006,869
Carmelo J Rizzo · Vanderbilt University · P01 · FY2013 · CA

Genetic Epidemiology of Lung Cancer

$1,006,509
Marshall W Anderson · University Of Cincinnati · U01 · FY2008 · CA

Mitigation of Radiation Induced Gastrointestinal Syndrome.

$1,005,819
Andrew John Norris · Bcn Biosciences, Llc · R44 · FY2024 · AI

Dayton Clinical Oncology Program

$1,005,000
Howard M Gross · Dayton Clinical Oncology Program · UG1 · FY2014 · CA

Role of the Epitranscriptome in Cancer

$1,005,000
Richard I. Gregory · Univ Of Massachusetts Med Sch Worcester · R35 · FY2025 · CA

Molecular Dynamics Simulations Of Biological Macromolecules

$1,004,608
Bernard R Brooks · National Heart, Lung, And Blood Institute · ZIA · FY2022 · HL

LUNG CANCER CHEMOPREVENTION WITH CELECOXIB IN EX-SMOKERS

$1,004,570
University Of California Los Angeles · U01 · FY2003 · CA

Precision microRNA medicine in cancer

$1,004,531
Frank J. Slack · Beth Israel Deaconess Medical Center · R35 · FY2023 · CA

Predevelopment of VV2003, a Novel CRAC Channel Inhibitor, to Improve Outcomes Associated with Checkpoint Inhibitor Immunotherapy

$1,004,278
Milton L Greenberg · Vivreon Biosciences, Llc · R44 · FY2019 · CA

Urine Diagnostics for Aspergillosis

$1,004,193
Kieren A. Marr · Pearl Diagnostics, Inc. · R42 · FY2017 · AI

Development of a Molecular Assay to Diagnose Malignant Pleural Effusions

$1,004,107
Mark A Nelson · Precision Epigenomics, Inc. · R44 · FY2024 · CA

Mesothelin-targeted immunotoxins in Pancreatic Cancer

$1,004,043
Christine Alewine · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

United for Health Equity - Living PDX Program (U4HELPP)

$1,003,591
Jose G. Trevino · Virginia Commonwealth University · U54 · FY2025 · CA

Special Mouse Strains Resource

$1,003,508
Leah Rae B Donahue · Jackson Laboratory · P40 · FY2009 · RR